Traditional veterinary oncology often uses general treatments that target fast-growing cells. These treatments may not work well for every dog because tumors can be very different genetically. This can cause treatments to be less effective and cause more side effects. New tools like next-generation sequencing and AI help doctors look at a dog’s tumor genes to find specific changes that cause cancer.
One example is FidoCure, a system that uses AI and has the largest database of canine cancer genetics. It stores over two billion data points. This system studies tumor genetics along with each dog’s life history to find mutations that drive cancer and matches them with targeted treatments.
FidoCure’s AI compares a dog’s tumor genes with cases that had similar tumors and good treatment results. The system learns over time by adding real treatment outcomes. This approach has helped with cancers like hemangiosarcoma, a tough cancer with few good options. Research shows the risk of death from this cancer can be cut by up to 50% using precision medicine.
The treatment process starts with sequencing the tumor’s genes. AI then finds mutations that can be targeted. Vets can prescribe treatments that focus on these mutations, not just general chemotherapy. This can make treatments work better and reduce side effects, helping dogs feel better during care.
Studies support FidoCure’s method, with more than 2,000 dogs treated in over 200 clinics in the U.S. Dogs like Forrest, a Golden Retriever with splenic cancer, lived much longer than expected after following FidoCure’s recommendations. Some dogs even had their tumors shrink or go away, giving hope to pet owners and vets.
AI cancer treatment platforms like FidoCure are strong not just because of technology but also thanks to partnerships with research institutions. FidoCure works with places like Tufts University and the Broad Institute of MIT and Harvard. These teams combine research with veterinary care to improve cancer treatment.
With data from more than 2,000 canine patients, these groups study tumor genetics and how different mutations respond to treatments. This helps the system make better predictions and supports vet decisions.
In September 2024, FidoCure received a patent for targeted therapy and biomarker detection in canine bladder cancer. This helps vets identify and treat specific bladder cancer types more accurately.
These partnerships keep veterinary oncology in the U.S. based on science and data. The goal is to make treatments more effective and tailored for dogs with cancer.
For practice managers and clinic owners, using AI for personalized cancer care brings both good chances and some challenges. Personalized treatments can improve dog health, make pet owners happier, and help clinics be leaders in advanced care. But clinics must invest in technology, train staff, and change how they work.
Veterinarians still lead treatments by using AI advice to choose the best care for each dog’s tumor. It is very important that treatments happen under a valid veterinarian-client-patient relationship (VCPR). This keeps things professional and ethical.
Clinics using data-driven approaches can leave behind guesswork treatments. This builds confidence and can lower side effects or treatments that don’t help. Stories from pet owners whose dogs lived longer or got better show how AI helps in real life.
AI use goes beyond tumor genetics. It also helps with clinic work and managing cancer care better. Here are some practical AI uses in vet clinics:
Together, these AI tools make clinic work easier, improve care, and keep records accurate. IT managers must focus on smooth integration and protecting sensitive data.
More vets in the U.S. are starting to use AI tools in cancer care. Evidence shows these tools help with patient results and clinic work. Vets are using AI for gene analysis, imaging, and managing workflows as the technology gets better.
Events like the Animal Health Summit show that companies want to push these tools forward. For example, FidoCure’s AI engine, Fetch™, speeds up finding suitable drugs and treatments. This shortens the usual time it takes to develop new cancer drugs, helping dogs and their owners sooner.
Clinics using AI-driven care can expect better results, faster workflows, and improved communication with pet owners. But ongoing training is needed for vets and staff to use the tools well.
Healthcare managers and IT staff need to think about several things when adding AI and genomic analysis to care:
AI-driven genomic analysis in dog cancer care is becoming a big part of veterinary oncology in the U.S. Platforms like FidoCure offer treatment plans based on large amounts of data. This helps dogs get better care and supports vets in decisions. AI also aids in medical notes, imaging, remote care, and patient monitoring, creating smoother workflows and better management. Practice leaders and IT teams play a big role in using these AI tools well to provide good cancer care to dogs across the country.
Scribenote is an AI-powered clinical documentation system that processes veterinary conversations in real-time to generate comprehensive medical records, improving documentation accuracy while reducing administrative burdens.
Vetology uses advanced AI diagnostic systems to rapidly analyze veterinary imaging data, providing detailed clinical reports within minutes while ensuring high accuracy through human-AI collaboration.
Digitail is an integrated AI practice management ecosystem that automates workflows, from medical records to client communication, allowing seamless operation and real-time data synchronization across all modules.
GoldieVet transforms audio recordings into detailed medical records using AI-powered transcription, enabling veterinary teams to accurately document various clinical scenarios while ensuring data security.
HappyDoc provides real-time transcription and customizable workflows that automatically convert clinical conversations into medical documentation, allowing vets to focus more on patient care and reducing burnout.
FidoCure analyzes complex genomic data to create personalized cancer treatments for dogs, utilizing next-generation sequencing and a vast database to improve therapeutic strategies.
ImpriMed uses AI to process live cancer cells to predict optimal treatment paths for pets, offering personalized medicine through rapid drug response testing and comprehensive diagnostics.
PetPace employs a smart collar to track real-time pet biometrics, detecting changes in wellness patterns through continuous monitoring of vital signs and behaviors to enable early intervention.
Petriage simplifies pet health assessments through an AI-driven engine that delivers rapid care guidance with 97% accuracy, connecting pet owners to licensed veterinary professionals.
ScribbleVet automatically processes clinical conversations into polished medical records using natural speech processing, ensuring accurate documentation while facilitating client communication with medical explanations.